- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Mid-Large Cap Stocks
Global Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
499
Mid-Large Cap Stocks
499 companies
Lonza Group
Market Cap: CHF 39.9b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 560.60
7D
-1.0%
1Y
9.5%
Evotec
Market Cap: €1.3b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€7.04
7D
0.9%
1Y
-23.4%
Denali Therapeutics
Market Cap: US$2.0b
A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
DNLI
US$13.66
7D
-3.5%
1Y
-29.1%
Trulieve Cannabis
Market Cap: CA$14.8b
Operates as a cannabis retailer.
TRUL
CA$5.82
7D
-10.0%
1Y
-59.6%
BeiGene
Market Cap: US$25.6b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$238.76
7D
5.8%
1Y
52.9%
Novavax
Market Cap: US$1.2b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
NVAX
US$7.29
7D
15.9%
1Y
-51.9%
Krystal Biotech
Market Cap: US$3.7b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$125.29
7D
-3.9%
1Y
-23.4%
Teva Pharmaceutical Industries
Market Cap: US$19.0b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$16.94
7D
0.4%
1Y
1.1%
BridgeBio Pharma
Market Cap: US$6.2b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$32.97
7D
-2.3%
1Y
18.8%
Viking Therapeutics
Market Cap: US$3.1b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$27.73
7D
1.2%
1Y
-55.0%
Prestige Consumer Healthcare
Market Cap: US$4.2b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$85.01
7D
-2.4%
1Y
33.2%
Celldex Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$20.37
7D
1.3%
1Y
-43.9%
Arcellx
Market Cap: US$3.3b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$65.54
7D
11.0%
1Y
20.8%
Veracyte
Market Cap: US$2.3b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$27.61
7D
-3.1%
1Y
27.7%
PTC Therapeutics
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$46.21
7D
-1.2%
1Y
19.6%
West Pharmaceutical Services
Market Cap: US$15.5b
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
WST
US$208.95
7D
1.1%
1Y
-37.5%
Tarsus Pharmaceuticals
Market Cap: US$1.9b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$43.19
7D
0.7%
1Y
20.7%
Amicus Therapeutics
Market Cap: US$2.0b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$6.34
7D
7.8%
1Y
-34.8%
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$44.31
7D
-0.2%
1Y
69.0%
ImmunityBio
Market Cap: US$2.6b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.65
7D
6.4%
1Y
-61.8%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥10.5b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥28.57
7D
7.4%
1Y
-27.1%
InventisBio
Market Cap: CN¥13.7b
A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.
688382
CN¥23.72
7D
19.6%
1Y
175.8%
SanBio
Market Cap: JP¥236.2b
Develops, produces, and sells regenerative cell medicines for the central nervous system.
4592
JP¥3,280.00
7D
17.7%
1Y
587.6%
Genscript Biotech
Market Cap: HK$25.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$11.76
7D
15.5%
1Y
7.1%
BrightGene Bio-Medical Technology
Market Cap: CN¥20.5b
A pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.
688166
CN¥48.65
7D
-0.9%
1Y
28.6%
Piramal Pharma
Market Cap: ₹273.5b
Operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally.
PPLPHARMA
₹206.32
7D
-1.1%
1Y
38.0%
LigaChem Biosciences
Market Cap: ₩4.0t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩110,600.00
7D
8.1%
1Y
66.1%
InnoCare Pharma
Market Cap: HK$23.1b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.96
7D
13.3%
1Y
132.2%
Alphamab Oncology
Market Cap: HK$8.6b
A clinical stage biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology biologics.
9966
HK$8.98
7D
35.4%
1Y
85.9%
Mabwell (Shanghai) Bioscience
Market Cap: CN¥9.4b
A biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products in China and internationally.
688062
CN¥23.47
7D
28.0%
1Y
-28.7%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩127,900.00
7D
2.9%
1Y
13.3%
Keymed Biosciences
Market Cap: HK$11.2b
A biotechnology company, focuses on in-house discovery and development of biological therapies in the autoimmune and oncology therapeutic areas.
2162
HK$40.70
7D
0.9%
1Y
14.8%
CanSino Biologics
Market Cap: HK$11.6b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.15
7D
5.2%
1Y
46.0%
BGI Genomics
Market Cap: CN¥19.8b
Provides genomic sequencing and proteomic services in China and internationally.
300676
CN¥51.80
7D
-8.7%
1Y
30.8%
Swedish Orphan Biovitrum
Market Cap: SEK 106.5b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 300.40
7D
-2.1%
1Y
7.2%
Siegfried Holding
Market Cap: CHF 4.2b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 94.90
7D
0.1%
1Y
5.8%